HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

autosomal recessive Spastic paraplegia 26

Also Known As:

Spastic paraplegia 26, autosomal recessive; SPG26

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Nervous System Diseases: 14178
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Congenital Abnormalities: 25723
  - Nervous System Malformations: 35
    - Hereditary Sensory and Motor Neuropathy: 249
      - Hereditary Spastic Paraplegia: 528
        autosomal recessive Spastic paraplegia 26: 3
- Inborn Genetic Diseases: 11939
  - Nervous System Heredodegenerative Disorders: 63
    - Hereditary Sensory and Motor Neuropathy: 249
      - Hereditary Spastic Paraplegia: 528
        autosomal recessive Spastic paraplegia 26: 3

Related Diseases

1.	Rare Diseases (Rare Disease)

Experts

1.	Alecu, Julian Emanuel: 1 article (09/2022)
2.	Bhuiyan, Robiul H: 1 article (09/2022)
3.	Ebrahimi-Fakhari, Darius: 1 article (09/2022)
4.	Furakawa, Koichi: 1 article (09/2022)
5.	Furukawa, Keiko: 1 article (09/2022)
6.	Inamori, Kei-Ichiro: 1 article (09/2022)
7.	Inokuchi, Jin-Ichi: 1 article (09/2022)
8.	Jumo, Hellen: 1 article (09/2022)
9.	Kambe, Mariko: 1 article (09/2022)
10.	Manabe, Noriyoshi: 1 article (09/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to autosomal recessive Spastic paraplegia 26:

1.	GangliosidesIBA 07/11/2013 - "Interestingly, although the catabolism of gangliosides is implicated in a variety of neurological diseases, SPG26 is only the second human disease involving defects of their biosynthesis. " 01/01/2022 - "Our approach illustrates the importance of careful phenotyping and functional characterization of novel gene variants, particularly in the setting of ultra-rare diseases, and expands the clinical and molecular spectrum of SPG26, a disorder of complex ganglioside biosynthesis."
2.	(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA 01/01/2023 - "Patients with a mutant GM2/GD2 synthase gene (SPG26) showed similar clinical signs, not only in terms of the neurological aspects, but also in the male reproductive system. "